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Abstract
Background: Lymphocyte-depleted Hodgkin’s lymphoma is the rarest form of classical Hodgkin’s lymphoma,
accounting for<1% of all cases. Patients often have advanced-stage disease at the time of presentation with an
aggressive clinical course. Even more uncommon is primary extranodal disease and rarely it will be presenting with
spinal cord compression.
Case presentation: An 88-year-old Caucasian female presented with a history of upper back pain for several
months and new onset bilateral leg numbness and weakness. MRI of the spine showed a dorsal epidural lesion
with cord compression at T1-T4 with involvement of the paraspinal muscles. The patient received urgent surgical
decompression, with final histopathology showing a lymphocyte-depleted Hodgkin’s lymphoma. Systemic work-up
did not show evidence of nodal disease. Following surgery, she received a course of radiotherapy with good
outcome.
Conclusion: To the best of our knowledge, this is the first reported case of primary lymphocyte-depleted Hodgkin
lymphoma presenting as epidural spinal cord compression. Our report, in conjunction with a review of the
literature, suggests that surgical intervention is clearly indicated in de novo disease followed by radiotherapy.
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Background
Hodgkin’s lymphoma (HL) usually presents with painless
enlargement of peripheral lymph nodes, mostly in the
cervical region in 90% of cases, with only 10% arising
from extranodal regions [1]. Approximately 5-20% of
patients with HL develop osseous involvement during
the course of their disease [2-6], but only 0.25% present
in a primary fashion [7].
Epidural lymphomas are observed in 0.1-6.5% of all
lymphomas and only 5% of patients with HL develop
spinal cord compression during the course of their disease
[8-10]. There are only a handful of reports of primary epi-
dural spinal HL (PESL; Table 1) [1,8,9,11-13] [14,15].
Patients usually present with back pain and/or neuro-
logic deficits specific to the level of the lesion, along with
lymphoma-related B-type symptoms of weight loss,
night sweats, and fever. Tumors have a preference for
the dorsal aspect of the thoracic spine, followed by lum-
bar and cervical regions, likely due to the rich venous
anatomy in the thoracic region [8,16,17]. The absence of
bony involvement limits the usefulness of plain films.
PESL appears isointense on T1-weighted images and is
iso- to hyperintense on T2-weighted MRI with marked
contrast enhancement [17,18]. MRI can clearly delineate
the tumor as well as the involvement of the surrounding
tissues. To complete the diagnostic workup of PESL, one
should also include a contrast MRI of the entire neur-
axis, body CT scan, bone marrow biopsy, bone scan, and
CSF analysis [9,19].
Lymphocyte-depleted Hodgkin’s lymphoma (LDHL) is
rarest subtype of classic Hodgkin’s lymphoma (CHL), ini-
tially recognized in 1966 [20], and comprising approxi-
mately<1% of all cases of CHL [21]. Morphologically,
these tumors can mimick other anaplastic malignancies
including non-Hodgkin’s lymphomas, nodular sclerosis
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oma, sarcoma, and melanoma [22]. Many earlier cases of
LDHL have since been reclassified as anaplastic variants
of diffuse large B-cell lymphoma or anaplastic large cell
lymphoma [22]. LDHL has a male predominance (60-75%
of cases) with an median age range of 30-37 years [23,24]
with a predilection for nodes in the retroperitoneum,
abdomen, thorax, and abdomen, with relative sparing of
the peripheral lymph nodes [21,25]. A recent study has
found an association between LDHL and HIV-positive
status [26].
Morphologically, LDHL can be distinguished from
other subtypes of CHL by the presence of numerous
Hodgkin and Reed-Sternberg (RS) cells and a relative
paucity of background lymphocytes, with a variable fi-
brotic reaction [22]. An extensive battery of immunos-
taining must be performed to further distinguish LDHL
from diffuse B-cell lymphomas, anaplastic large-cell
lymphoma, or nodular sclerosis CHL with lymphocyte
depletion. A review of seven cases of LDHL showed ex-
pression for CD30, CD15, fascin, weak PAX5 and
MUM-1 markers but lacked CD45, Alk-1, EMA, CD3,
CD68, Mart-1 and cytokeratin [22]. For ease of refer-
ence, we have included a table outlining immunohisto-
chemical markers for both LDHL and Non-Hodgkin’s
lymphoma (NHL; Table 2).
Goals of treatment echo those of any lesion causing
epidural spinal cord compression: decompression of the
neural elements, tissue diagnosis, and spinal stabilization
[27]. In cases of primary disease presenting with spinal
cord compression, surgical debulking is mandated and
also allows for adequate tissue sampling for diagnosis
[19]. This is followed by radiation therapy alone or in
conjunction with chemotherapy but rarely with chemo-
therapy alone [19,28,29]. Rathmell et al reported a 33%
actuarial survival rate in patients treated with radiation
alone compared to 86% with combination therapy [30],
while Monnard et al found that combined treatment
was statistically superior to radiotherapy alone [19]. This
is similar to treatment for NHL, although therapy for
NHL varies according to the histological type and dis-
ease grading, with chemotherapy alone for nonindolent
variants, while radiotherapy alone is used in indolent
stage I and contiguous stage II NHL. This is in contrast
to emerging treatment of indolent noncontiguous stage
II, III, and IV NHL with antibodies directed to present-
ing B-cell antigens in combination with systemic chemo-
therapy. Aggressive NHL is treated using a combination
of chemotherapy and involved-field radiation therapy,
which has shown to be more effective than just chemo-
therapy alone. To the best of our knowledge, there have
been no previous reports of a primary epidural spinal
LDHL causing spinal cord compression. We herein re-
port our findings to highlight this extremely rare subtype
of CHL and also to emphasize the importance of diligent
investigation in a patient that presents with back pain
and unremarkable plain film xrays.
Case presentation
History
An 88 year-old Caucasian female was seen by the neuro-
surgical service with worsening pain between her scap-
ula and difficulties ambulating. She had had upper back
pain for several months. She underwent work up with
plain films which did not show any abnormalities, and
had been managed conservatively by pain management
clinics. Over the past 4 weeks, she had developed pro-
gressive lower extremity weakness, requiring a walker
for ambulation. She was admitted to hospital for medical
management of her back pain and over the course of the
next 48 hours, she had subjective worsening of her lower
limb weakness. A review of systems was negative for ma-
lignancy or B-type symptoms.
Examination
Physical examination was negative for lymphadenopathy.
Neurologic examination was significant for a positive
Rhomberg’s sign and decreased pinprick sensation in
Table 1 Evidentiary table of case reports of primary epidural spinal Hodgkin’s lymphomas
Case Report Patient Levels of Disease Neurologic Findings
Al-Khayat H et al, 2007 47 yo female C7, T1 Bilateral hand weakness
Cagavi F et al, 2006 30 yo male C6, L3 Low back pain
Citow JS et al, 2001 54 yo female T4,5 Upper back pain
Higgins SA et al, 1995 46 yo female C5-T8 Lower extremity numbness
Illes A et al, 2002 32 yo male T11-12 Paralysis
Table 2 Immunohistochemical markers for Lymphocyte-depleted Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma
Lymphoma Subtype Expressed Markers
LDHL PAX5 (weak), CD30, CD15, MUM-1, fascsin, Oct.2 or Bob-1 (not co- expressed)
NHL PAX5 (strong), CD20, CD79a (B cell NHL), EMA, ALK-1, Oct.2 and Bob-1 (always co-expressed)
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distribution). She had loss of proprioception in all ex-
tremities. Rectal tone was normal. Toe responses were
described as extensor on the left and equivocal on the
right. Blood panel showed normal values apart from
slight anaemia and mildly elevated platelets.
Imaging
Since plain films had been normal, an MRI of the thor-
acic and lumbar spine was ordered, showing an epidural
lesion from T2 to T4 levels (Figure 1A) with involve-
ment of the posterior left T4 vertebral body (Figure 1B),
posterior elements of T2 and T3, as well as extension
through the left T2-3 and T3-4 neural foramina
(Figures 1C & D). The lesion caused significant cord
compression with evidence of mild cord edema.
Management
The patient was taken urgently to the operating room
for a decompressive laminectomy from T1-T4. The epi-
dural mass was diligently resected to decompress the
cord. Frozen tissue histology confirmed a malignant
infiltrative tumor initially suggestive of a carcinoma,
which prompted us to also excise the surrounding
involved paraspinal tissues. Given her advanced age, ex-
tensive tumor burden, and preexisting comorbidities, we
opted for a wide decompression of the spinal cord but
no further aggressive surgical measures.
Pathology
The tumor displayed a fibrotic background without
frank sclerosis, increased numbers of large atypical cells
and a dearth of small lymphoid cells (Figures 2A & B).
At high magnification large lymphoid cells with abun-
dant eosinophilic cytoplasm predominated. Most of the
large cells exhibited prominent inclusion-like eosino-
philic nucleoli with perinucleolar clearing and many of
the cells were multinucleated (Figures 2C & D). Large
pleomorphic cells, multinucleated cells, and mummified
cells were the predominant cell populations in the
tumor. There was an abundance of CD30+RS cells, but
neither the B cell lineage marker CD20, nor CD45 were
expressed by RS cells. The B-cell transcription factor
Bob-1 was positive only in rare large neoplastic cells
which were admixed against a scant background of pre-
dominantly T lymphocytes, but PAX5 was weakly posi-
tive in many of the cells a feature that is characteristic of
classical HL. Based on the combined presence of a dom-
inant population of RS cells with the immunophenotype
characteristic of classical HL and apaucity of lympho-
cytes, our pathology colleagues, deduced that this patient
presented with a classic example of an extremely rare
form of classical HL denominated LDHL.
Postoperative course
Following surgery, she had persistent loss of propriocep-
tion with an unsteady gait, which we attributed second-
ary to prolonged compression of the dorsal columns by
the circumferential tumor mass. She demonstrated mye-
lopathic symptoms with mild hyperreflexia to her lower
extremities and Babinski reflexes on postoperative exam
(which were present prior to surgical decompression).
Systemic workup, including a PET study, did not show
nodal disease or presence of extranodal involvement
outside of the symptomatic thoracic region. CSF was not
examined due to the primary epidural nature of the dis-
ease. Combination therapy was offered to the patient,
but after extensive counseling, she opted for radiother-
apy alone, not wanting to experience the possibly signifi-
cant side-effects of chemotherapy and the resultant need
for prolonged hospital stay to receive treatment. She
thus received ten treatments of external beam radiation
at 3 Gy fractions for a total of 30 Gy, from which she
was experiencing mild fatigue, esophagitis, and moderate
erythema to the treatment area. At the end of therapy,
she had 5/5 strength in the upper and regained 4/5
strength in the lower extremities on exam. She was
transferred to a palliative care unit where she lived well
Figure 1 Imaging of the spine demonstrating the epidural tumor mass. A) Sagittal T2-weighted MRI showing the dorsal epidural lesion with
cord compression. B) Axial T2-weighted MRI showing circumferential epidural compression of the spinal cord by the tumor mass with, C) tumor
extension through the intervertebral foramen with lateral extension into the paraspinal tissues.
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months.
Conclusion
Bone involvement is common during the course of both
Hodgkin’s and non-Hodgkin’s lymphoma, but rarely pre-
sents with epidural spinal cord compression. The initial
manifestation of such lymphoproliferative disorders in
the spine is a very rare entity and even more so when
encountered as an isolated disease focus, hence its place
on the list of differential diagnosis in patients who
present with back pain and compressive myelopathy are
unfamiliar to most clinicians. The clinical, radiological,
and histological features of this disease can mimic other
medical conditions leading to canal compromise, includ-
ing pathological compression fractures, infectious lesions
(such as tuberculosis and osteomyelitis), or carcinomat-
ous deposits. This makes the correct diagnosis difficult
and often leads to significant delays until effective treat-
ment is initiated.
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